AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2685688
Drug: Vindesine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vindesine (3 mg/m2 i.v.) and Mitoxantrone (10 mg/m2 i.v.) every 3 weeks x 3 and every 4 weeks thereafter (VM)
Trial: 2685688
Drug: Vindesine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vindesine (3 mg/m2 i.v.) and Epirubicin (40 mg/m2 i.v.) every 3 weeks x 3 and every 4 weeks thereafter (VE)
Trial: 28406648
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy (n = 119)
Trial: 28406648
Drug: Dynamic therapy
RxNorm normalized name: AVOBENZONE 3 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / OXYBENZONE 6 g in 100 mL TOPICAL LOTION [PHOTO DYNAMIC THERAPY SPF 30]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dynamic therapy (n = 118)
Trial: 23715669
Drug: Colloid administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloid administration (41 patients)
Trial: 23715669
Drug: No colloid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No colloid administration (82 patients)
Trial: 19223438
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy (adjunctive)
Trial: 19223438
Drug: Benzodiazepines (adjunctive,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzodiazepines (adjunctive, N=10)
Trial: 16512804
Drug: Synbiotics (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotics (1.2 x 10^9 CFU Lactobacillus rhamnosus Lcr35 plus prebiotic preparation)
Trial: 16512804
Drug: Prebiotics alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prebiotics alone (identically appearing prebiotic preparation)
Trial: 22762855
Drug: Generic rosuvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic rosuvastatin 40 mg tablet (Zentiva)
Trial: 22762855
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations (Generic and Reference)
Trial: 17921912
Drug: Valacyclovir 500
RxNorm normalized name: valacyclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 500 mg qd
Trial: 15893095
Drug: Anabolic steroid
RxNorm normalized name: Anabolic steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anabolic steroid prevention program
Trial: 12789994
Drug: Colgate Simply
RxNorm normalized name: Colgate
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colgate Simply White Clear Whitening Gel (18% carbamide peroxide), applied for 30 minutes, twice daily, for 3 weeks.
Trial: 12789994
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel (control group).
Trial: 9585288
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg of midazolam plus 75 microg of fentanyl
Trial: 9585288
Drug: 3 mL
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mL of saline
Trial: 2554716
Drug: Danpro-S (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danpro-S (0.8 g.kg‐1.d‐1)
Trial: 2554716
Drug: Danprotex-H 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danprotex-H 40 (0.8 g.kg‐1.d‐1)
Trial: 489192
Drug: BM 15.100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BM 15.100 (20 mg, single oral dose, administered 60 min prior to allergen inhalation)
Trial: 489192
Drug: BM 15.000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BM 15.000 (10 mg)
Trial: 29641737
Drug: One time
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One time high dose 300,000 IU of ergocalciferol (VD2)
Trial: 25586124
Drug: Propofol 3
RxNorm normalized name: fospropofol 35 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 3 mg · kg(‐1) over 3 min
Trial: 18972900
Drug: Dexpanthenol spray
RxNorm normalized name: Dexpanthenol
DrugBank: Dexpanthenol (DB09357)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexpanthenol spray (Mar plus)
Trial: 11109181
Drug: Domiciliary chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domiciliary chemotherapy
Trial: 11109181
Drug: Hospital-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital-based chemotherapy
Trial: 8941405
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m2/wk
Trial: 8941405
Drug: Paclitaxel 200
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 200 mg/m2/wk
Trial: 1604414
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose pulse methotrexate (MTX, 5‐7.5mg/week)
Trial: 4055545
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil 500 mg tid (open study)
Trial: 4055545
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil 500 mg bd (comparative study)
Trial: 4055545
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil 500 mg tid (comparative study)
Trial: 4055545
Drug: Amoxycillin 500
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 500 mg tid (comparative study)
Trial: 30747025
Drug: Intracervical Foley
RxNorm normalized name: eladocagene exuparvovec
DrugBank: Eladocagene exuparvovec (DB16780)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical Foley catheter combined with dinoprostone gel (0.5 mg) for 12 hours followed by oxytocin
Trial: 28373691
Drug: Doxycycline (MMP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (MMP inhibitor), dosage and duration not specified
Trial: 25149295
Drug: 1-L polyethylene
RxNorm normalized name: polyethylenes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-L polyethylene glycol and four tablets of bisacodyl with 90 mL of Iopamidol on the same day as CTC examination (group 1)
Trial: 25149295
Drug: Standard 'iodine-only'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard 'iodine-only' preparation, consisting of 180 mL of Iopamidol the day before the examination (group 2)
Trial: 20008774
Drug: 0.5% Glycerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% Glycerol monolaurate (GML) gel
Trial: 20008774
Drug: 5% Glycerol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% Glycerol monolaurate (GML) gel
Trial: 20008774
Drug: 0% Control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0% Control gel
Trial: 20008774
Drug: Control and
RxNorm normalized name: DIMETHICONE 0.58 mL in 45 mL CUTANEOUS CREAM [SUPER CREAM AGE CONTROL AND FIRMING]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control and GML gels
Trial: 18957013
Drug: Intraperitoneal heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal heparin (specifically low-molecular weight heparin)
Trial: 18957013
Drug: Intraperitoneal heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal heparin
Trial: 15777683
Drug: 6007C >
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6007C > T polymorphism (TT vs. CC)
Trial: 15777683
Drug: 6007C >
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6007C > T polymorphism (CT vs. CC)
Trial: 12456902
Drug: Steroid (prednisolone)
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Steroid (prednisolone) + amoxicillin for 14 days, then amoxicillin for 14 more days
Trial: 12456902
Drug: Steroid (prednisolone)
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Steroid (prednisolone) + amoxicillin for 14 days, then placebo for amoxicillin for 14 more days
Trial: 12456902
Drug: Placebo (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (for steroid) + amoxicillin for 14 days, then amoxicillin for 14 more days
Trial: 12456902
Drug: Placebo (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (for steroid) + amoxicillin for 14 days, then placebo for amoxicillin for 14 more days
Trial: 12456902
Drug: Steroid +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid + amoxicillin
Trial: 12456902
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + amoxicillin
Trial: 10651262
Drug: Troglitazone 400
RxNorm normalized name: troglitazone 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 400 mg daily for 16 weeks
Trial: 7734716
Drug: NHL855 protocol
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NHL855 protocol consisting of vincristine, prednisolone, cyclophosphamide, doxorubicin, high-dose methotrexate (HD-MTX), mercaptopurine, cytarabine, CNS prophylaxis with intrathecal MTX and hydrocortisone.
Trial: 29880847
Drug: Twice or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice or three times 100 mg aspirin daily dosing
Trial: 29880847
Drug: Long-term persistence
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term persistence of superior biochemical efficacy with multiple dosing
Trial: 18362499
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) replacement therapy for 2 years
Trial: 22011460
Drug: Fish-oil capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish-oil capsules (1720 mg DHA and 600 mg EPA daily)
Trial: 12376165
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (triphasic OCs)
Trial: 9669832
Drug: Albuterol inhaled
RxNorm normalized name: albuterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol inhaled as a microfine powder
Trial: 12145664
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy with ribavirin
Trial: 12145664
Drug: Pegylated therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated therapy
Trial: 12145664
Drug: Pegylated combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated combination therapy with high dose ribavirin
Trial: 12145664
Drug: Sustained responders
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained responders regardless of therapy
Trial: 12145664
Drug: Pegylated combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated combination therapy
Trial: 24786931
Drug: IV golimumab
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: IV golimumab 2 mg/kg + MTX
Trial: 15655049
Drug: alpha‐interferon (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha‐interferon (3 MU thrice weekly) + ribavirin (1000‐1200 mg/day) for 48 weeks
Trial: 15655049
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (current standard management)
Trial: 12369033
Drug: Subcutaneous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous lidocaine (0.2 mL 1%) by jet injector
Trial: 12369033
Drug: No anesthetic
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anesthetic with a sham injection
Trial: 1977029
Drug: High-dose Edmonston-Zagreb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose Edmonston-Zagreb (EZ) measles vaccine
Trial: 1977029
Drug: Conventional Schwarz
RxNorm normalized name: measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection [Priorix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Schwarz vaccine
Trial: 28323627
Drug: CCXG injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCXG injection (100 mL, intravenous drips, 3 times a day)
Trial: 28323627
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (100 mL of 10% normal saline injection, 3 times a day)
Trial: 26040478
Drug: Misoprostol 200
RxNorm normalized name: MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol 200 mcg administered intravaginally 10 and 4 hours before IUC insertion attempt.
Trial: 26040478
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered intravaginally 10 and 4 hours before IUC insertion attempt.
Trial: 26040478
Drug: Misoprostol 200
RxNorm normalized name: MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol 200 mcg administered intravaginally.
Trial: 26040478
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered intravaginally.
Trial: 22035998
Drug: Bupropion plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion plus functional analytic psychotherapy (FAP) and acceptance and commitment therapy (ACT)
Trial: 19796802
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (Gabapentin + Nortriptyline)
Trial: 19796802
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment vs Gabapentin
Trial: 19796802
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment vs Nortriptyline
Trial: 12752353
Drug: Pellets (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pellets (500 mg of mesalazine and 2 mg of 152Sm2O3)
Trial: 12752353
Drug: Tablets (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablets (500 mg of mesalazine and 2 mg of 152Sm2O3)
Trial: 11078989
Drug: Oral fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fat load (OFLT) in obese subjects
Trial: 11078989
Drug: Oral fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fat load (OFLT) in healthy controls
Trial: 11078989
Drug: Oral fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fat load (OFLT) at 0700 h (diurnal test)
Trial: 11078989
Drug: Oral fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fat load (OFLT) at 2200 h (nocturnal test)
Trial: 11078989
Drug: Baseline insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Baseline insulin concentrations in obese subjects
Trial: 11078989
Drug: Baseline insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Baseline insulin concentrations in healthy controls
Trial: 8791965
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg twice daily
Trial: 1637562
Drug: Cream preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream preparations of triamcinolone acetonide and clobetasol propionate
Trial: 1637562
Drug: Ointment preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ointment preparations of triamcinolone acetonide and clobetasol propionate
Trial: 8008680
Drug: Acebutolol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (400 mg daily)
Trial: 29696061
Drug: Fennel vaginal
RxNorm normalized name: Fennel
DrugBank: Fennel (DB15615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fennel vaginal cream (5 grams) every night for 8 weeks
Trial: 29696061
Drug: Fennel vaginal
RxNorm normalized name: Fennel
DrugBank: Fennel (DB15615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fennel vaginal cream
Trial: 22710397
Drug: Magnesium citrate
RxNorm normalized name: Magnesium Citrate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium citrate (34 g administered at 8 p.m. the night before the examination)
Trial: 22710397
Drug: No preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preparation (no laxative administered)
Trial: 17204156
Drug: Alcohol and
RxNorm normalized name: Polyvinyl alcohol and povidone only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol and drug abuse and dependence (AAD/DAD) assessment using standardized procedures and structured interviews.
Trial: 17204156
Drug: Regular screening
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular screening and treatment programs for AAD/DAD in prison.
Trial: 7981578
Drug: Growth hormone-releasing
RxNorm normalized name: Growth hormone-releasing peptide 2
DrugBank: Pralmorelin (DB18252)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Growth hormone-releasing hormone (GHRH; 100 micrograms)
Trial: 2493400
Drug: Buserelin (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin (0.2 mg SC or 1.2 mg IN per day)
Trial: 1105370
Drug: Pyritinol-HCl 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyritinol-HCl 300 mg/24 hr
Trial: 26898264
Drug: Conventional drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional drug therapy (Control)
Trial: 24550190
Drug: AG (1
RxNorm normalized name: MGlcDAG (1->2) glucosyltransferase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AG (1 µg/kg/h)
Trial: 24550190
Drug: UAG (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UAG (4 µg/kg/h)
Trial: 23061628
Drug: Infliximab (5mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (5mg/kg in a single intravenous infusion)
Trial: 9773697
Drug: Intrathecal sufentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal sufentanil 2, 5, or 10 microg (2 mL volume) and epidural saline (10 mL)
Trial: 9773697
Drug: Epidural bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural bupivacaine 5, 12.5, or 25 mg and intrathecal saline (2 mL volume)
Trial: 9773697
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of intrathecal sufentanil (1, 2.5, and 5 microg) plus epidural bupivacaine (2.5, 6.25, or 12.5 mg)
Trial: 7828395
Drug: Potassium supplementation
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium supplementation (15 ml of potassium chloride with 0.9 mmol K per ml, three times a day) in group 2 (72 patients on diuretics)
Trial: 7828395
Drug: 2-day preparation
RxNorm normalized name: Caviar Preparation
DrugBank: Caviar, unspecified (DB14241)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-day preparation of 15 g magnesium sulphate and 10 mg bisacodyl twice daily in group 1 (55 patients on diuretics without potassium supplements)
Trial: 7828395
Drug: 2-day preparation
RxNorm normalized name: Caviar Preparation
DrugBank: Caviar, unspecified (DB14241)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-day preparation of 15 g magnesium sulphate and 10 mg bisacodyl twice daily in group 3 (97 patients)
Trial: 7828395
Drug: 1-day preparation
RxNorm normalized name: Caviar Preparation
DrugBank: Caviar, unspecified (DB14241)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-day preparation of 2.4 mg sennoside per kg in group 4 (96 patients)
Trial: 3338014
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy with chlorambucil for 2 years
Trial: 2149806
Drug: Gestodene preparation
RxNorm normalized name: gestodene
DrugBank: Gestodene (DB06730)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestodene preparation
Trial: 2149806
Drug: Desogestrel preparation
RxNorm normalized name: Desogestrel
DrugBank: Desogestrel (DB00304)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desogestrel preparation
Trial: 31651350
Drug: 8.25 mg
RxNorm normalized name: leucine 8.25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8.25 mg dexamethasone intravenously after 8 hours of hypoxia with an FiO2 of 12%
Trial: 18762944
Drug: Risedronate 5
RxNorm normalized name: risedronate 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 5 mg daily plus calcium (1,000 mg) and vitamin D (800 IU)
Trial: 18762944
Drug: Control (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (daily alfacalcidol (1 microg) plus calcium (500 mg) for those with prevalent vertebral fractures; daily vitamin D (800 IU) plus calcium (1,200 mg) for those without previous vertebral fractures)
Trial: 17786099
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg controlled-release doxycycline
Trial: 9744511
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with cisplatin and vinblastine followed by surgery
Trial: 9744511
Drug: Combined-modality treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined-modality treatment (chemotherapy and surgery)
Trial: 27250881
Drug: Weekly cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly cisplatin (35 mg/m2, 6 cycles)